Investments
Facebook files motions to dismiss state and FTC antitrust lawsuits
Facebook argues that the antitrust lawsuits filed by state and local governments should be dismissed. The social networking giant filed motions to dismiss on Wednesday, saying that the cases “do not credibly claim” that it harmed competition or consumers by its conduct. Q4 2020 hedge fund letters, conferences and more Facebook says FTC, state antitrust […]
The post Facebook files motions to dismiss state and FTC antitrust lawsuits appeared first on ValueWalk.
Read MoreStocks Bulls Can Take a Rest – But Gold Ones Can’t
The daily banging on the 3,900 threshold shows in yesterday‘s upper knot, and this milestone has very good chances of being conquered today. More important than the exact timing though, are the internals marking the setup – we‘ve indeed progressed very far into this correction. While not historically among the longest ones, it‘s still getting […]
The post Stocks Bulls Can Take a Rest – But Gold Ones Can’t appeared first on ValueWalk.
Read MoreNCRC Applauds Passage Of The American Rescue Plan
Today, the U.S. House of Representatives passed the American Rescue Plan – the new $1.9 trillion coronavirus stimulus package passed earlier this week in the Senate, and championed by President Biden, who is expected to sign the bill Friday. Q4 2020 hedge fund letters, conferences and more Applause For The Congress On Passing The American […]
The post NCRC Applauds Passage Of The American Rescue Plan appeared first on ValueWalk.
Read MoreSCOR gets quota share longevity retro from Mangrove sidecar
France-headquartered global reinsurance firm SCOR has put in place a sidecar-like, quota share retrocession vehicle named Mangrove Insurance PCC Limited through which it transfers some of its longevity risk to third-party investors. Mangrove Insurance PCC Limited is one of SCOR’s special purpose vehicles through which it taps the capital markets for retrocessional reinsurance capacity. Mangrove…
Read MoreDividend Aristocrats In Focus: Federal Realty Investment Trust
Updated on March 11th, 2021 by Bob Ciura When it comes to dividend growth stocks, the Dividend Aristocrats are the “cream of the crop”. These are stocks in the S&P 500 Index, with 25+ consecutive years of dividend increases. Additionally, the Dividend Aristocrats must meet certain market cap and liquidity requirements. It is relatively difficult…
Read MoreThe Gym Group: One of UK’s Best Reopening Plays
The GYM Group PLC (LON:GYM) is the second-largest low-cost gym operator in the UK. It has 184 locations and ~578K members as of January 2021. The company was one of the hardest-hit by the COVID pandemic. Despite those headwinds, GYM is the best-positioned company to take advantage of the UK reopening. Q4 2020 hedge fund […]
The post The Gym Group: One of UK’s Best Reopening Plays appeared first on ValueWalk.
Read More78% Of All SMBs Are Still Experiencing Negative Financial Effects
New Alignable March State Of Small Business Report Released: Shows Increased Levels Of Strife With One Silver Lining. Small businesses are still experiencing negative financial effects. Q4 2020 hedge fund letters, conferences and more From Alignable’s March State of Small Business Report. SMBs Are Still Experiencing Negative Financial Effects First, The Good News: Small business […]
The post 78% Of All SMBs Are Still Experiencing Negative Financial Effects appeared first on ValueWalk.
Read MoreChris Bloomstran And Berkshire Hathaway
During their recent episode of the VALUE: After Hours Podcast, Taylor, Brewster, and Carlisle discussed Chris Bloomstran And Berkshire Hathaway. Here’s an excerpt from the podcast: Q4 2020 hedge fund letters, conferences and more Chris Bloomstran And Berkshire Hathaway Jake: Yeah. Then the last thing I want to hit was, Chris Bloomstran has this incredible […]
The post Chris Bloomstran And Berkshire Hathaway appeared first on ValueWalk.
Read MorePfizer CEO Bourla: 94% Vaccine Efficacy On Asymptomatic
First on CNBC: CNBC Transcript: Pfizer Chairman and CEO Albert Bourla speaks with CNBC’s “Squawk Box” today about their vaccine being 94% effective and preventing asymptomatic infection. Q4 2020 hedge fund letters, conferences and more WHEN: Today, Thursday, March 11 WHERE: CNBC’s “Squawk Box” Following is the unofficial transcript of a CNBC interview with Pfizer […]
The post Pfizer CEO Bourla: 94% Vaccine Efficacy On Asymptomatic appeared first on ValueWalk.
Read More